scholarly journals Salivary Duct Carcinoma: Case Reports and Brief Review of the Literature

2021 ◽  
Vol 2021 ◽  
pp. 1-4
Author(s):  
Deepti Kantamani ◽  
Sai S. Bandaru ◽  
Jennifer L. Miatech ◽  
M. Patrick Stagg

Salivary duct carcinoma (SDC) is an uncommon and highly aggressive tumor associated with high morbidity and mortality. According to the World Health Organization, it is an extremely rare malignancy with an estimated incidence of 1-1.2 in 1,000,000 patients. Standard treatment for SDC is wide surgical resection along with lymph node dissection followed by adjuvant radiation therapy. The role of adjuvant chemotherapy is not known. In this report, we present three cases of SDC. A 71-year-old female with T1N0M0 disease was treated with total parotidectomy, ipsilateral neck dissection, and adjuvant radiotherapy without evidence of disease recurrence at 5 months. The second is a 59-year-old female with TXN1M0 disease who was treated with total parotidectomy with ipsilateral level I-IV neck dissection and adjuvant radiotherapy without evidence of disease occurrence at 21 months. The third case is a 79-year-old male with widely metastatic disease, including brain metastases, treated with cranial irradiation, leuprolide, and lapatinib who remains under home hospice care.

2013 ◽  
Vol 127 (6) ◽  
pp. 621-624
Author(s):  
W F Mourad ◽  
K S Hu ◽  
R A Shourbaji ◽  
L B Harrison

AbstractBackground:Sarcomatoid salivary duct carcinoma of the submandibular gland is extremely rare. This paper highlights the impact of surgery and adjuvant radiation therapy on the outcome of this disease.Methods:A 59-year-old man with human immunodeficiency virus presented with a painless, rapidly growing left neck mass. Biopsy followed by surgical excision of the left submandibular gland revealed sarcomatoid salivary duct carcinoma of the submandibular gland duct with perineural invasion and close margins, for which he underwent adjuvant radiotherapy. Post-operative positron emission tomography and computed tomography revealed no residual or metastatic disease. Pathological analysis of tumour–node–metastasis staging revealed a T2 N0 M0 (stage II) tumour.Results:The patient tolerated his treatment without serious acute or long-term side effects. There was no evidence of disease on comprehensive examination or on positron emission tomography or computed tomography scans at the 4.6-year follow up.Conclusion:Surgery followed by adjuvant radiotherapy provided practical locoregional control with acceptable toxicity. Further detailed case reports are warranted to optimise the management of this rare malignancy.


2001 ◽  
Vol 94 (12) ◽  
pp. 1105-1110 ◽  
Author(s):  
Tsuyoshi KITANISHI ◽  
Hiroya KITANO ◽  
Akira SHIBANO ◽  
Michiko YOSHII ◽  
Tomoya NAGATA ◽  
...  

2016 ◽  
Vol 95 (9) ◽  
pp. E15-E17 ◽  
Author(s):  
Kenji Noda ◽  
Takashi Hirano ◽  
Tomoyo Okamoto ◽  
Masashi Suzuki

This report describes a salivary duct carcinoma (SDC) arising from the extraglandular portion of the Stensen duct. The patient was a 56-year-old man who presented with a palpable, elastic, hard mass without tenderness in the right cheek. Computed tomography revealed a tumor of the extraglandular portion of the Stensen duct. Supraomohyoid right neck dissection and total right parotidectomy were performed, and the histologic diagnosis was SDC of the Stensen duct. Postoperatively, the patient received no additional treatment. Neither recurrence nor metastasis was observed during 4 years of follow-up examination. SDC of the Stensen duct is extremely rare. To our knowledge, there is no report that describes primary SDC arising from that location. We also believe this is the first report that describes the clinical course of primary SDC arising from a Stensen duct.


Pathology ◽  
2008 ◽  
Vol 40 (4) ◽  
pp. 434-437 ◽  
Author(s):  
Tamazin Leecy ◽  
Michael E. Buckland ◽  
Jennifer Turner ◽  
Peter Earls

Diagnostics ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 1312
Author(s):  
Shih-Lung Chen ◽  
Chi-Ju Yeh ◽  
Kai-Chieh Chan

Background: Salivary duct carcinoma (SDC) is a rare aggressive tumor. Most tumors are not confined to the salivary ducts; rather, they invade the major and minor salivary glands. Only a few case reports on such tumors in other primary sites have appeared. Case presentation: A 40-year-old male complained of right hearing loss (a common condition), but we made an extremely rare diagnosis of an SDC in the external auditory canal (EAC). EAC cancers are frequently misdiagnosed. In our patient, the otoscope revealed a smooth, bulging subcutaneous lesion with a non-epithelial defect suggestive of a benign lesion. However, an SDC of the EAC was confirmed through pathological and immunohistochemical analysis. Conclusions: We suggest detailed evaluation of even smooth EAC subcutaneous lesions to avoid erroneous diagnoses. To the best of our knowledge, this is the first report of SDC in the EAC.


2014 ◽  
Vol 2014 ◽  
pp. 1-3
Author(s):  
Winfred Kitavi ◽  
Ulrich Hamberger ◽  
Holger Sudhoff

Salivary duct carcinomas (SDCs) are high-grade malignant tumors exhibiting aggressive growth with early regional and distant metastasis. We report a case of SDC in a 63-year-old male with early recurrent disease in the cerebellopontine angle (CPA) after total parotidectomy and adjuvant radiotherapy. The tendency of the tumor to recur or metastasize despite radical surgical measures and radiotherapy continues to pose a therapeutic challenge.


2018 ◽  
Vol 11 (1) ◽  
pp. bcr-2018-226636
Author(s):  
Ameya Asarkar ◽  
Amol Takalkar ◽  
Manish Dhawan ◽  
Cherie Ann O Nathan

Salivary duct carcinoma (SDC) is a rare and extremely aggressive salivary gland cancer. An 81-year-old woman with SDC underwent a total parotidectomy with facial nerve sacrifice and a neck dissection. Following surgery, she was diagnosed with disseminated bone marrow metastases. She underwent chemotherapy and trastuzumab for palliation. We present a case of SDC of the parotid which was diagnosed with disseminated bone marrow metastasis following surgery for the primary. This case also highlights the importance of having a high index of suspicion while evaluating highly aggressive tumours like SDC for any atypical findings during workup.


2002 ◽  
Vol 95 (5) ◽  
pp. 493-499
Author(s):  
Tomoko TATEYA ◽  
Hiroyuki KITAMURA ◽  
Shin-ichi TAKAGITA ◽  
Yuka IWAHASHI ◽  
Yasutaka KAWATA ◽  
...  

2011 ◽  
Vol 23 (3) ◽  
pp. S45-S46 ◽  
Author(s):  
F. McGrane ◽  
R.K. Shrimali ◽  
A.G. Robertson ◽  
C. Paterson ◽  
P.D. Correa

2020 ◽  
pp. 1-3
Author(s):  
Peer W. Kämmerer ◽  
D. Schneider ◽  
Peer W. Kämmerer

Salivary duct carcinoma (SDC) represents a very rare and aggressive parotid neoplasm. A 70-year-old male was admitted to the hospital with a swelling of the right parotid region, persisting for twelve weeks. Based on sonography and contrast-enhanced computed tomography, a suspicious lesion showing mass expansion and invasion of surrounding tissues was seen. Intraoperative biopsy brought evidence of SDC. In accordance, surgical treatment included parotidectomy with preservation of the facial nerve as well as ipsilateral neck dissection due to suspicious lymphatic nodes. Afterwards, an adjuvant radiation therapy was undertaken. At 10 years of follow-up, the patient was alive and free of recurrence with full function of the facial nerve. In conclusion, keeping in mind its poor prognosis, the rare parotid salivary duct carcinoma needs aggressive therapy consisting of a surgical as well as a radiation therapy approach.


Sign in / Sign up

Export Citation Format

Share Document